These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1925 related articles for article (PubMed ID: 30376874)
41. Long non‑coding RNA Unigene56159 promotes glioblastoma multiforme cell proliferation and invasion through negatively regulating microRNA‑194‑5p. Jiang G; Dong H; Dong Y; Yang X Mol Med Rep; 2020 Feb; 21(2):768-776. PubMed ID: 31789416 [TBL] [Abstract][Full Text] [Related]
42. LncRNA and mRNA expression profiles of glioblastoma multiforme (GBM) reveal the potential roles of lncRNAs in GBM pathogenesis. Li Q; Jia H; Li H; Dong C; Wang Y; Zou Z Tumour Biol; 2016 Nov; 37(11):14537-14552. PubMed ID: 27604987 [TBL] [Abstract][Full Text] [Related]
43. LncRNA GAPLINC promotes the growth and metastasis of glioblastoma by sponging miR-331-3p. Chen HH; Zong J; Wang SJ Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):262-270. PubMed ID: 30657584 [TBL] [Abstract][Full Text] [Related]
44. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein. Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955 [TBL] [Abstract][Full Text] [Related]
45. Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer. Liu Z; Chen Z; Fan R; Jiang B; Chen X; Chen Q; Nie F; Lu K; Sun M Mol Cancer; 2017 Apr; 16(1):82. PubMed ID: 28441948 [TBL] [Abstract][Full Text] [Related]
46. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression. Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003 [TBL] [Abstract][Full Text] [Related]
47. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer. Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390 [TBL] [Abstract][Full Text] [Related]
48. lncRNA KTN1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑505‑3p. Mu Y; Tang Q; Feng H; Zhu L; Wang Y Oncol Rep; 2020 Dec; 44(6):2645-2655. PubMed ID: 33125151 [TBL] [Abstract][Full Text] [Related]
49. MicroRNA‑376a inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting specificity protein 1. Li Y; Wu Y; Sun Z; Wang R; Ma D Mol Med Rep; 2018 Jan; 17(1):1583-1590. PubMed ID: 29257212 [TBL] [Abstract][Full Text] [Related]
50. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429. Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494 [TBL] [Abstract][Full Text] [Related]
51. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis. Coward WR; Feghali-Bostwick CA; Jenkins G; Knox AJ; Pang L FASEB J; 2014 Jul; 28(7):3183-96. PubMed ID: 24652950 [TBL] [Abstract][Full Text] [Related]
52. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2. Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140 [TBL] [Abstract][Full Text] [Related]
53. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240 [TBL] [Abstract][Full Text] [Related]
54. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108 [TBL] [Abstract][Full Text] [Related]
55. Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma. Costa BM; Smith JS; Chen Y; Chen J; Phillips HS; Aldape KD; Zardo G; Nigro J; James CD; Fridlyand J; Reis RM; Costello JF Cancer Res; 2010 Jan; 70(2):453-62. PubMed ID: 20068170 [TBL] [Abstract][Full Text] [Related]
56. No Significant Cytotoxic Effect of the EZH2 Inhibitor Tazemetostat (EPZ-6438) on Pediatric Glioma Cells with Wildtype Histone 3 or Mutated Histone 3.3. Wiese M; Schill F; Sturm D; Pfister S; Hulleman E; Johnsen SA; Kramm CM Klin Padiatr; 2016 Apr; 228(3):113-7. PubMed ID: 27135271 [TBL] [Abstract][Full Text] [Related]
57. EZH2 regulates the malignancy of human glioblastoma cells via modulation of Twist mRNA stability. Zhai X; Li LS; Zhou YD; Ji WY; Chen H; Xiao H; Liang P Eur J Pharmacol; 2021 Aug; 904():174177. PubMed ID: 34015321 [TBL] [Abstract][Full Text] [Related]
58. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme. Zhang K; Li Q; Kang X; Wang Y; Wang S Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337 [TBL] [Abstract][Full Text] [Related]
59. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9. Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279 [TBL] [Abstract][Full Text] [Related]
60. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme. Ghasemi A; Fallah S; Ansari M Biochem Cell Biol; 2016 Dec; 94(6):569-576. PubMed ID: 27783537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]